tetradecanoylphorbol acetate has been researched along with quinapril in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Major, TC; Overhiser, RW; Panek, RL; Taylor, DG | 1 |
| Erinola, M; Tepel, M; van der Giet, M; Zidek, W | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and quinapril
| Article | Year |
|---|---|
Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Hypertension; In Vitro Techniques; Isoquinolines; Male; Mesenteric Arteries; Phenylephrine; Potassium Chloride; Quinapril; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Tetradecanoylphorbol Acetate; Tetrahydroisoquinolines; Vasoconstriction | 1993 |
Captopril and quinapril reduce reactive oxygen species.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cells, Cultured; Dose-Response Relationship, Drug; Enalaprilat; Fluoresceins; Fluorescent Dyes; Humans; Isoquinolines; Leukocytes, Mononuclear; Lisinopril; NADPH Oxidases; Quinapril; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Tetrahydroisoquinolines | 2002 |